Related Experiment Videos

[Risk factor: diabetes mellitus]

M Tominaga1

  • 13rd Department of Internal Medicine, Yamagata University School of Medicine.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|February 1, 1995
PubMed

Insights

Diabetic microangiopathy is less common in individuals with shorter diabetes duration and lower blood glucose. Macroangiopathy, however, shows no difference, suggesting other factors contribute to atherosclerosis.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Research

Context:

  • Diabetes mellitus is a global health concern with significant microvascular and macrovascular complications.
  • Early detection and management are crucial for preventing long-term sequelae.
  • Mass screening programs offer a unique opportunity to study disease prevalence in asymptomatic populations.

Purpose:

  • To compare the prevalence of diabetic microangiopathy and macroangiopathy between asymptomatic individuals identified through mass screening and symptomatic patients attending a university hospital outpatient clinic.
  • To investigate the relationship between glycemic control, diabetes duration, and the development of vascular complications.

Summary:

  • A study in Funagata, Japan, compared diabetic patients from mass screening with hospital outpatients.
  • The mass-screening group had lower fasting blood glucose and shorter diabetes duration, with significantly lower rates of microangiopathy (retinopathy, microalbuminuria, neuropathy).
  • Electrocardiogram (EKG) ischemic changes, a marker of macroangiopathy, did not differ between groups, indicating hyperglycemia's primary role in microvascular complications but suggesting multifactorial causes for macrovascular disease.

Impact:

  • Findings support the Diabetes Control and Complications Trial (DCCT) hypothesis linking hyperglycemia to microangiopathy.
  • Highlights the multifactorial nature of diabetic macroangiopathy and atherosclerosis, involving factors beyond hyperglycemia such as hypertension and dyslipidemia.
  • Emphasizes the importance of comprehensive risk factor management in diabetes care to prevent both micro- and macrovascular complications.

Related Concept Videos